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Silent catalytic promiscuity in the high-ﬁdelity
terpene cyclase δ-cadinene synthase†
Marianna Loizzi, David J. Miller and Rudolf K. Allemann *
δ-Cadinene synthase (DCS) is a high-ﬁdelity sesquiterpene synthase that generates δ-cadinene as the sole
detectable organic product from its natural substrate (E,E)-FDP. Previous work with this enzyme using
substrate analogues revealed the ability of DCS to catalyse both 1,10- and 1,6-cyclisations of substrate
analogues. To test whether this apparent promiscuity was an artefact of alternate substrate use or an
inherent property of the enzyme, aza analogues of the proposed α-bisabolyl cation intermediate were
prepared since this cation would be formed after an initial 1,6-cyclisation of FDP. In the presence of
250 μM inorganic disphosphate both (R)- and (S)-aza-bisaboyl cations were potent competitive inhibitors
of DCS (Ki = 2.5 ± 0.5 mM and 3.44 ± 1.43 μM, respectively). These compounds were also shown to be
potent inhibitors of the 1,6-cyclase amorpha-4,11-diene synthase but not of the 1,10-cyclase aristolo-
chene synthase from Penicillium roquefortii, demonstrating that the 1,6-cyclase activity of DCS is most
likely an inherent property of the enzyme even when the natural substrate is used and not an artefact of
the use of substrate analogues.
Introduction
Terpene synthases catalyse some of the most complex reac-
tions in the natural world. From a small pool of isoprenyl
diphosphates they generate a myriad of hydrocarbons and
alcohols that are often processed into thousands of terpenoids
with diverse biological activities with many potential appli-
cations for instance as agrochemicals or therapeutic agents.1
The details of terpene synthase chemistry2 have been inves-
tigated by site directed mutagenesis and with non-natural
amino acids,3 analogues of substrates,4 and putative reaction
intermediates,5 X-ray crystallography,2b,c,6 and computational
modelling.2d,7 Together these investigations revealed a fasci-
nating, yet still incomplete picture. A series of X-ray crystal
structure of aristolochene synthase from Aspergillus terreus in
both closed and open conformations along with complexes
containing the complete substrate (or analogue), diphosphate
anion and/or Mg2+ co-factors8 revealed the physical steps of
the catalytic cycle. Binding of a Mg2+-ion is followed by coordi-
nation of the prenyl diphosphate substrate and a second Mg2+
ion; coordination of a third Mg2+ ion triggers active site
closure to form the Michaelis complex.8 Diphosphate cleavage
is then triggered to form an initial carbocation and the hydro-
phobic active site shelters this high energy intermediate from
bulk solvent.2b,c The active site, lined with hydrophobic and
aromatic amino acid residues then steers the initial carbo-
cation through a series of ring closures and rearrangements
prior to quench of the final carbocation either by proton loss
or nucleophilic attack by water.2b,c,6e Usually this is tightly con-
trolled by the enzyme, with a single enantiomer dominating
the product pool whereby several rings and stereocentres are
often generated in a single chemical step from an achiral pre-
cursor. Control of this process is thought to arise from a
product-like active site contour in combination with direction
of carbocation location in the intermediates through the nega-
tive charge on the diphosphate anion and aromatic amino
acid side chains that can stabilise carbocations at certain
locations through cation–π interaction.2b,c,4a A small subset of
terpene synthases, on the other hand, exhibit significant
promiscuity, presumably through having a less structured and/
or flexible active site that allows the intermediates to sample a
large number of reactive conformations prior to final carbo-
cation quench. For example, δ-selinine synthase and
γ-humulene synthases from Abies grandis generate 34 and 52
products from farnesyl diphosphate (1), respectively.9 Terpene
synthases have been postulated to evolve through such pro-
miscuous intermediates prior to further evolution into high-
fidelity synthases.3e The modern δ-cadinene synthase (DCS)
from Gossypium arboreum is a high-fidelity sesquiterpene
synthase that catalyses the formation of the bicyclic hydro-
carbon (+)-δ-cadinene (7),10 the first committed step in the bio-
synthesis of the phytoalexin gossypol.11 The catalytic domain
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is situated in the C-terminal domain and adopts the α-helical
fold domain, typical of class 1 terpene synthases.2b,c,12 It con-
tains the conserved aspartate rich motif D307DTYD311 on helix
D, but instead of the usual characteristic NSE/DTE Mg2+
binding motif, DCS has a second aspartate rich motif
D451DVAE455 on helix H.6e Despite only generating a single
detectable hydrocarbon product, extensive mechanistic ana-
lysis of the DCS-catalysed reaction pathway has not unambigu-
ously defined the chemical steps of its catalytic cycle.
Moreover, conversion of fluorinated and stereochemically
altered FDP analogues with DCS revealed an underlying
mechanistic promiscuity with products arising from an initial
1,10-, 1,6- or 1,11-ring closure depending upon the substrate
analogue used (vide infra).12 Two chemical mechanisms
remain plausible for the formation of δ-cadinene from FDP
(Scheme 1). Both pathways involve initial formation of (3R)-
nerolidyl diphosphate ((3R)-NDP, (2)) as an enzyme-bound
intermediate. In pathway (a), a 1,10-macrocyclisation occurs to
generate cis-germacradienyl cation (4). A subsequent [1,3]-
hydride shift is followed by a 1,6-electrophilic ring closure to
cadinenyl cation (6), from which δ-cadinene (7) is formed after
proton loss from C6. In pathway (b), a 1,6 ring-closure of 2 is
followed by a [1,3]-hydride shift from C1 to C7; subsequently a
second ring closure and a [1,5]-hydride shift lead to cadinenyl
cation, an intermediate common to both pathways. In previous
work, using substrate analogues we were unable to definitively
rule out pathway (b) and indeed when 6-fluorofarnesyl di-
phosphate (6F-FDP) was used as a substrate analogue it proved
to be a potent inhibitor (Ki = 2.4 μM), giving no detectable
pentane-extractable products when incubated with DCS. This
result is consistent with an initial 1,6-cyclisation pathway since
it would be expected to undergo 1,10-ring closure and give an
abortive product rather than inhibit the enzyme in the latter
scenario. On the other hand, 2-fluorofarnesyl diphosphates
(2F-FDP) and 10-fluorofarnesyl diphosphate (10F-FDP) gave
products arising from 1,10- and 1,11 ring-closures, respect-
ively, consistent with an initial 1,10-ring closure mechanism.12
Hence examination of the catalytic mechanism of DCS
using FDP analogues has led to inconclusive, yet intriguing
results, showing that this enzyme has the potential to use
alternative reaction pathways. Yet the question arises, is this
simply an artefact of the substrate used or is this an inherent
property of the enzyme? The work described here provides
alternative mechanistic data for the DCS-catalysed transform-
ation of FDP to δ-cadinene using aza-analogues of putative car-
bocation intermediates. Although the highly unstable carbo-
cationic intermediates formed during terpene synthase cataly-
sis, cannot be isolated, it is possible to replace the sp2 hybri-
dised carbocationic carbon of a given intermediate with an sp3
hybridised nitrogen in an amine analogue or with a sp2 hybri-
dised nitrogen in an iminium ion. Although the tetrahedral
tertiary ammonium ions inherently are imperfect geometric
analogues of the planar carbocations, these aza-terpenoids are
thought to mimic the topological and electrostatic properties
of carbocations generated by these enzymes.5 However, since
they cannot be processed by the enzyme, they often act as
tightly bound competitive inhibitors of terpene synthases.5c,13
Hence, the use of strategically designed aza-analogues may
enable the disentanglement of the possible reaction mecha-
nisms catalysed by DCS. Here we report the stereoselective syn-
thesis of the two enantiomers of aza-bisabolyl cation and their
kinetic evaluation as inhibitors of DCS. Comparison of their
eﬀect upon catalysis by AS and amporpha-4,11-diene synthase
(ADS), enzymes that follow 1,10- and 1,6-ring-closure mecha-
nisms, validate the result that DCS has inherent 1,6- as well as
1,10 ring closure activity.
Results and discussion
If α-bisabolyl cation 8 is a reaction intermediate on the
pathway to δ-cadinene (7), one or both of enantiomeric aza-
analogues of 11 (Fig. 1) should act as competitive inhibitors of
DCS.
Both enantiomers of 11 have previously been prepared.14a
Here we report an alternative synthesis that is more concise
and avoids the use of harsh reaction conditions. Key to the
synthesis of both enantiomers is an enantioselective synthesis
of the two enantiomers of carboxylic acid 18 (Scheme 2). This
was achieved through asymmetric Diels–Alder reaction of an
Scheme 1 Possible chemical steps for DCS catalysed production of
δ-cadinene from FDP (1).
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acrylate derivatised with a chiral auxiliary with a butadiene.15
Oxazolidin2-one 12 was alkylated with acryloyl chloride after
deprotonation with n-butyl lithium with 35% yield. The result-
ing ester 13 was then subjected to an asymmetric Diels–Alder
reaction with 2-methylbutadiene.15 The enantioselectivity and
yield were optimal at −100 °C in CH2Cl2 (52%, ee >95%, de
>95% (see ESI† for details). This produced the key compound
to generate the S enantiomer of the aza-analogue 11. The equi-
valent R configured ester was generated using D-pantolactone
(15) as a chiral auxiliary.15 After alkylation with acryloyl chlor-
ide, using NEt3 as the base in CH2Cl2, diester 16 was isolated
in 60% yield. Again, an asymmetric Diels–Alder reaction with
2-methylbutadiene was carried out, this time at −10 °C in
CH2Cl2 using TiCl4 as a Lewis acid catalyst yielding the R ester
in 84% yield (ee = 92% and de = 97%).16 The latter procedure
was in fact optimal for both enantiomers but due to the high
cost of L-pantolactone not used for bulk preparation for the
R-enantiomer of 18. Optical purity of all subsequent com-
pounds was checked using chiral GC, HPLC and/or polarime-
try and in all cases no loss of optical purity was detected in
later synthetic steps.
Both syntheses now proceeded in identical manner and
Scheme 2 only illustrates the synthesis of the S-enantiomer of
11. Hydrolysis of 14 using LiOH in an equivolume mixture of
THF, water and methanol for 1 h at 50 °C gave carboxylic acid
18 in near quantitative yield. 18 was converted to p-methoxy-
benzyl urethane derivative 19 by treatment with diphenylpho-
sphorylazide (DPPA) followed by a Curtius rearrangement in
the presence of p-methoxybenzyl alcohol, which proceeded
with strict retention of stereochemistry.15b The overall yield of
the urethane product 19 was 60% over the two steps. Final con-
version to (S)-11 was achieved first through reduction with
LiAlH4 in anhydrous Et2O (50%) then HBTU mediated coup-
ling to 4-methypent-3-enoic acid (70%) followed by a second
reduction with LiAlH4 in Et2O. To prevent air oxidation upon
storage the product was converted to its hydrochloride salt
with HCl in ether, yielding (S)-11·HCl in 55% yield over the
final two steps. The optical purity of (S)-11 was estimated to be
≥98% by comparison with previously reported data.14a Similar
results were obtained for the synthesis of (R)-11.
To validate any results obtained for these compounds as
inhibitors of DCS, they were tested as inhibitors of aristolo-
chene synthase from Penicillium roqueforti (AS) and amorpha-
4,11-diene synthase (ADS). These two enzymes are known to
proceed via 1,10- and 1,6-cyclisations of the initial carbocation
during their catalytic cycle (Scheme 3).1g Hence aza-bisabolyl
cations 11 should act as poor inhibitors of AS and potent
inhibitors of ADS, as they closely resemble a reaction inter-
mediate in the latter case only.
Recombinant AS and ADS were prepared and purified
according to previously published procedures17,18 and both
Fig. 1 Chemical structures of the α-bisabolyl cation (8) and corres-
ponding aza analogues (R)-11 and (S)-11.
Scheme 2 Synthesis of aza-analogues (R)- and (S)-11. Reagents and
conditions: (i) acryloyl chloride, BuLi, THF, 35%. (ii) Et2AlCl, CH2Cl2,
−100 °C, 54%. (iii) Acryloyl chloride, NEt3, CH2Cl2, 60%. (iv) TiCl4,
CH2Cl2, −10 °C, 84%. (v) LiOH, THF, H2O, MeOH, 50 °C, 99%. (vi) DPPA,
NEt3. (vii) p-Methoxybenzyl alcohol, toluene, 60% over two steps. (viii)
LiAlH4, Et2O, 50%, (ix) 4-methylpent-3-enoic acid, EtNPr
i
2, HBTU, DMF,
70%. (x) LiAlH4, Et2O. (xi) HCl in Et2O, 55% two steps.
Scheme 3 Initial catalytic chemical steps leading to (c) (+)-aristolo-
chene (22) and (d) amorpha-4,11-diene (23) follow 1,10- and 1,6-cyclisa-
tion of FDP, respectively.
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(R)-11 and (S)-11 were tested as inhibitors using a standard
radiolabelled assay involving conversion of tritium labelled
FDP by each enzyme and scintillation counting of the pentane
extractable products.5b Terpene synthases are known to
eﬃciently bind cation-PPi pairs and inhibition was assessed
both in the presence and absence of 250 μM diphosphate
(Table 1). Synergistic inhibition of aza-analogues 11 with
diphosphate has been observed previously for a variety of
other terpene synthases.5d,13c,14
Kinetic data were fitted by non-linear regression to the
Michaelis–Menten equation (v0 = kcat[E][S]/(KM + [S]). The
mode of inhibition was determined by inspection of double
reciprocal plots and observed to be competitive in all cases
where inhibition was significant at low concentrations of 11.
KI was determined from a plot of inhibitor concentration
versus K′M/(kcat[E]) where K′M = KM(1 + [I]/KI).
The inhibition data for AS and ADS validate both of these
compounds as valuable mechanistic probes for the present
investigation since they are poor inhibitors of AS and potent
inhibitors of ADS. PPi had little eﬀect on the ability to inhibit
AS (KI > 200 μM in both the presence and absence of PPi for
AS). Both enantiomers of 11 acted as competitive inhibitor of
ADS, showing that they are able to compete eﬀectively with the
natural substrate FDP at the active site. As these aza-com-
pounds cannot be turned over by ADS, these result support the
intermediacy of an α-bisabolyl cation in the biosynthesis of
amorpha-4,11-diene, in agreement with the findings of Picaud
et al.18b who used deuterated farnesyl diphosphate and deuter-
ium exchange experiments to suggest that the R-enantiomer of
the α-bisabolyl cation is the sole intermediate formed in the
biosynthesis of amorpha-4,11-diene. Therefore, only the R
enantiomer of 11 would be expected inhibit ADS; however, if
the S-enantiomer was a slightly more potent inhibitor (Ki =
50 μM for (R)-11 versus 25 μM for (S)-11) Table 1. This is con-
sistent with a flexible model for sesquiterpene active sites,
according to which an active site can accommodate a variety of
intermediates of diﬀerent shape and charge distribution
without being rigidly complementary to a single intermediate
or transition state species. For example, work by Cane et al.
showed that both enantiomers of the aza-analogue 11 were
equally eﬀective inhibitors of trichodiene synthase.14a It is also
notable that the presence of PPi enhanced inhibition of ADS
by both enantiomers, improving the Ki approximately 20-fold
(Ki = 1.5 and 3.7 μM for the S and R enantiomers respectively)
demonstrating that the active site of ADS prefers a cation–
anion pair in its active site.5d,13
Recombinant DCS was generated with a C-terminal hexahis-
tidine tag (DCS-His6) as previously described.
19 Inhibition
assays were carried out using the same protocol used for AS
and ADS. Both aza analogues were found to be competitive
inhibitors of DCS-His6 in the presence of PPi but only poor
inhibitors in its absence (Table 1). DCS clearly requires a
cation–anion pair in its active site for eﬀective inhibition by
aza-analogues. Our results provide strong evidence for 1,6-
cyclase activity for DCS.
Conclusions
The aza-bisabolyl cations 11 were potent competitive inhibi-
tors of ADS, a 1,6-cyclase yet were much poorer inhibitors of
PR-AS, a known 1,10-cyclase. When DCS was challenged with
these aza-analogues in the presence of diphosphate anion they
were potent inhibitors of the conversion of FDP to
(+)-δ-cadinene (7), which would only be expected if DCS had a
1,6-cyclase activity. The use of a variety of substrate analogues
possessing diﬀerent stereochemistry and heteroatoms did not
lead to clear results regarding whether DCS follow a 1,6 or 1,10
pathway.12 If the proposed initial isomerism of the substrate to
nerolidyl diphosphate (2) was suppressed using a fluorine
atom at C2 then a 1,10 cyclisation was observed (Fig. 2).
2-Fluorogemacrene A (25) was the DCS catalysed product from
the transoid (2Z,6E)-2-fluorofarnesyl diphosphate (24) while
the cisoid substrate analogue 26 gave the cisoid product 2F-
helminthogermacrene A (27).12 However, in nearly every other
case involving the use of substrate analogues with DCS, 1,6-
cyclisation was observed at least in-part (Fig. 2).12 These
results may simply reflect the use of diﬀerent substrates rather
than an inherent ability of DCS to catalyse the conversion of
FDP to 7 along two distinct reaction paths.20 The observation
that 11 acts as a competitive inhibitor of the DCS catalysed
conversion of FDP provides strong evidence that DCS can
eﬃciently use a 1,6-cyclisation pathway.
The fact that inorganic diphosphate led to a more tightly
bound active site carbocation/diphosphate ion pair is consist-
ent with previous work where often the active site recognises a
cation-PPi pair more eﬀectively than the cation alone.5b,c–7a,14
The fact that (R)-11 acts as a weak inhibitor in the absence of
PPi is more diﬃcult to explain. It was previously suggested
that, in the DCS active site pocket, the alkenyl chain of (3R)-
nerolidyl diphosphate (2) is ideally positioned to ensure the
formation of the α-bisabolyl cation with an R configuration at
C6 (Scheme 1).12 The C1–C7 hydride shift from 8 to 9 then
occurs to the same Si face of C7 in cation 8, therefore a (7R)-9
formation is expected (Scheme 1). Hence the (R)-11 should
mimic better the α-bisabolyl cation generated by this enzyme,
and therefore act as competitive inhibitor with higher binding
aﬃnity when compared with the S-enantiomer. The evidence
Table 1 Kinetic data for inhibition of ADS, AS and DCS by (R)-(11) and
(S)-11. Uninhibited kinetic data for each enzyme: ADS KM = 2 ± 0.15 μM
kcat = 1.19 × 10
−2 ± 52 × 10−5 s−1. AS KM = 2.42 ± 0.11 μM, kcat = 1 × 10−2
± 2 × 10−5 s−1. DCS-His6 KM = 0.58 ± 11 μM kcat = 1.26 × 10−3 ± 5 ×
10−6 s−1
Enzyme Aza-analogue Ki (μM) (+250 μM PPi) Ki (μM)
ADS (S)-11 1.5 ± 0.5 25 ± 5
(R)-11 3.7 ± 1.9 50 ± 17
AS (S)-11 255 ± 23 295 ± 23
(R)-11 489 ± 62 472 ± 48
DCS (S)-11 3.44 ± 1.43 273 ± 77
(R)-11 2.5 ± 0.5 1700 ± 300
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that both enantiomers of 11 are equally as eﬀective in the pres-
ence of PPi is consistent with a permissive model of the active
site structure, according to which an active site should accom-
modate a variety of rearranged intermediates of diﬀerent
shape and charge distribution without being rigidly comp-
lementary to a single intermediate. On the other hand, their
lack of inhibitory eﬀects on the 1,10-cyclase PR-AS shows that
a major diﬀerence in the connectivity of the aza-analogue com-
pared to the carbocation intermediate (i.e. bisabolyl cation
rather than the 10-membered ring containing germacrenyl
cation) renders them ineﬀective as inhibitors; hence the 1,6-
cyclase activity of DCS postulated previously12 is intrinsic to
the enzyme.
Terpene synthases can generate great structural and stereo-
chemical complexity in one synthetic step and have therefore
potential as powerful synthetic biocatalysts for the generation
of many bioactive compounds.4f,18a,21,22 A clear understanding
of the catalytic strategies employed by these enzymes can aid
their redesign to produce nature-like compounds that are not
found in the biosphere.23,24
Experimental
General experimental procedures, enzyme preparation and
purification are described in ESI† along with kinetics data, gas
chromatograms, mass spectra and NMR spectra.
(R)-4,4-Dimethyl-2-oxotetrahydrofuran-3-yl acrylate (16)
Freshly distilled propenoyl chloride (0.41 mL, 5 mmol) was
added over 1 h to a stirred solution of (R)-pantolactone
(500 mg, 3.84 mmol) and Et3N (583 mg, 5.76 mmol) in an-
hydrous CH2Cl2 (10 mL) at −24 °C. The resulting mixture was
stirred for 5 h at −24 °C, and subsequently washed with
aqueous 1 M HCl (10 mL). The aqueous phase was then
extracted with CH2Cl2 (3 × 20 mL). The combined organic
phases were washed with saturated NaHCO3 solution (3 ×
20 mL), water (3 × 20 mL) and brine (3 × 20 mL). The organic
phase was dried over MgSO4, concentrated under reduced
pressure and the residue was purified by flash chromatography
on silica (EtOAc : hexane 4 : 6) to yield the pure compound as a
yellow oil (375 mg, 53%). δH (300 MHz, CDCl3) 6.48 (1 H, d, J =
17.5, CHHvC), 6.18 (1H, dd, J = 17.5, 10.5 Hz, CHvCH2), 5.93
(1H, d, J = 10.5 Hz, CHHvC), 5.40 (1H, s, CvOCH–O), 4.03 (2
H, s, CH2–OCvO), 1.17 (3 H, s, CH3), 1.08 (s, 3 H, CH3);
δC (63 MHz, CDCl3) 174.7 (OCvOCHO), 172.5 (OCvOCvH2),
134.0 (H2CvCHCvO), 118.7 (H2CvCHCvO), 76.1
(OCvOCHO), 74.6 (OCH2CH), 40.2 (C–(CH3)2), 23.4 (CH3),
23.0 (CH3). αD +10° (CH2Cl2, c = 17). Data are in agreement
with previous work.15a
(R)-4.4-Dimethyl-2-oxotetrahydrofuran-3-yl-(S)-4-
methylcyclohex-3-ene-1-carboxylate (17)
To a solution of 16 (302 mg, 1.67 mmol) in anhydrous CH2Cl2
(5 mL) at −10 °C, TiCl4 (0.82 mL, 0.82 mmol, 1.0 M solution in
CH2Cl2) was added, and the resulting solution was stirred
under argon at −10 °C for 1 h. 2-Methylbutadiene (0.23 mL,
2.3 mmol) was then added over 5 min and the mixture was left
stirring for 3 h at −10 °C. The reaction was quenched by
addition of 10% Na2CO3 in water (5 mL). The aqueous phase
was then extracted with CH2Cl2 (3 × 20 mL). The organic layers
were combined, washed with H2O (3 × 10 mL), brine (3 ×
10 mL), dried over anhydrous MgSO4, filtered and concen-
trated under reduced pressure. The residue was purified by
flash chromatography on silica (EtOAc : hexane 2 : 8) to yield
pure 17 as a colourless oil (353 mg, 85% yield). δH (300 MHz,
CDCl3) 5.32 (1 H, s, OCHCvO,) and (1 H, br CHv), 3.98 (2 H,
s, CHCH2O), 2.69–2.51 (1 H, m, CH–CvO), 2.19 (2 H, m broad,
CHO–CH2Cv), 1.98 (3 H, m, CHH–CH2), 1.73 (1H, m, –CHH–
CH2), 1.58 (s, 3H, CH3Cv), 1.13 (3H, s, CH3), 1.04 (3 H, s,
CH3). δC (75 MHz, CDCl3) 174.7 (OCvOCHO), 172.5
(OCvOCvH2), 134.0 (HCvCCH3), 118.7 (HCvCCH3), 76.1
(OCvOCHO), 74.6 (OCH2C), 40.2 (C–(CH3)2), 38.9 (CH2CH–
CvO), 28.9 (HCvCCH2), 27.7 (CvCHCH2), 25.2
Fig. 2 Summary of 1,10 and 1,6 cyclisation products generated through
DCS catalysis.
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(HCvCCH2CH2), 23.4 (CCH3), 23.0 (CCH3), 19.8 (CH3CvCH).
LRMS (EI+) m/z: 252.13 (50%), 122.07 (20), 94.08 (100), 79.05
(30), 67.05 (10). αD −51.3 (CHCl3, c = 1). Data are in agreement
with previous work.16
(S)-3-Acryloyl-4-benzyloxazolidin-2-one (13)
To a solution of (S)-4-benzyloxazolidin-2-one (1.00 g,
5.60 mmol) in anhydrous THF (12 mL) at −78 °C, n-BuLi
(2.1 M in THF, 3.14 mL, 6.59 mmol) was added dropwise over
30 minutes and the mixture stirred for a further 3 h at −78 °C.
Freshly distilled acryloyl chloride (557 mg, 6.16 mmol) was
added dropwise over 20 minutes and the reaction stirred for
2 h at −78 °C. The reaction was then allowed to warm to room
temperature overnight. The reaction was quenched with sat.
NH4Cl (20 mL) and extracted with diethyl ether (3 × 30 mL).
The organic layer was washed with water (3 × 40 mL), saturated
aqueous NaHCO3 (3 × 40 mL), dried (MgSO4), filtered, and
concentrated under reduced pressure. Flash chromatography
on silica gel (hexane : ethyl acetate 6 : 4) aﬀorded 13 as a color-
less solid (452 mg, 35%). δH (CDCl3, 300 MHz) 7.45 (dd, 1H,
J = 6.0, 18.0, CHvCH2), 7.23 (m, 5H, aromatic Hs), 6.54 (dd,
1H, JH, H = 18.0, 18.0, CHHvCH2), 5.87 (dd, 1H, J = 9.0, 9.0,
CHHvC), 4.68 (m, 1H, CHN), 4.14 (m, 2H, CH2O), 3.29 (dd,
1H, J = 9.0, 9.0, CvCHHPh), 2.74 (dd, 1H, J = 12.0, 12.0,
CHHPh) αD −86° (CH2Cl2, c = 0.65). Data are in agreement
with previous work.14a
(R)-4-Benzyl-3-((S)-4-methylcyclohex-3-enecarbonyl)oxazolidin-
2-one (14)
To a stirred solution of 13 (200 mg, 0.86 mmol) at −100 °C,
were added 2-methylbutadiene (1.72 mL, 17.2 mmol) in anhy-
drous CH2Cl2 (5.0 mL) and Et2AlCl (1.2 mL, 1.5 eq.). The reac-
tion was stirred at −100 °C for 30 min then the mixture was
poured into ice cold aqueous hydrochloric acid (1 M, 20 mL).
The mixture was extracted with CH2Cl2 (2 × 10 mL). The com-
bined organic layers were dried over anhydrous MgSO4,
filtered, and concentrated under reduced pressure. The
product was purified by flash chromatography on silica
(EtOAc : hexane : Et3N 92 : 7 : 1) to yield the Diels Alder adduct
(14) as a white crystalline solid (139 mg, 54%). δH (300 MHz,
CDCl3) 7.34–7.10 (5 H, m, ArCH), 5.36 (1 H, br., CHvC), 4.63
(1 H, dt, J = 16.6, 6.9, CHN), 4.23–3.95 (2 H, m, CH2O), 3.60
(1 H, t, J = 8.8, CHCvO), 3.20 (1 H, dd, J = 13.2, 3.3, CHHPh),
2.70 (1 H, dd, J = 13.3, 9.5, CHHPh), 2.20–1.6 (6 H, m,
CH2CH2CHCH2CvC), 1.64 (3H, s, CH3) αD +79 (CH2Cl2, c =
1.4). LR-MS (EI+) m/z: 299.15 (100% M+), 300.16 (15), 269.06
(18), 267.07 (50), 232.10 (20), 178.08 (100), 146.07 (30), 140.03
(55), 122.07 (20), 91.00 (65), 63.00 (30). Data are in agreement
with previous work.14a
(R)- and (S)-4-Methylcyclohex-3-ene-1-carboxylic acid (18)
To a solution of 14 or 17 (0.32 mmol) in THF :MeOH : H2O
(1 : 1 : 1, 1.5 mL), LiOH (67 mg, 1.6 mmol) was added, and the
resulting mixture was vigorously stirred for 1 h at 50 °C. The
reaction was then cooled to room temperature and concen-
trated under reduced pressure. The resulting slurry was dis-
solved in H2O (10 mL) and extracted with CH2Cl2 (3 × 5 mL).
The resulting aqueous phase was acidified to pH = 2 at 0 °C
with 15% HCl, extracted with a mixture of n-pentane : CH2Cl2
(98 : 2 3 × 10 mL), dried over anhydrous Na2SO4, and concen-
trated under reduced pressure to give 18 as a white powder
(35 mg, 80%). δH (CDCl3, 300 MHz) δ 5.32 (1H, s, CHv),
2.54–2.39 (1 H, m, CH–COOH), 2.17 (2H, m, –CH2CHvC), 1.93
(3 H, m, CHH–CH2), 1.69 (1H, m, CHH–CH2), 1.59 (3H, s,
CH3). δC (100 MHz, CDCl3) δ 182.3 (HOCvO), 133.8
(HCvCCH3), 119.0 (CH2–HCvCCH3), 39.0 (HC–COOH), 29.13
(CH2CvCH3), 27.3 (CH2CHvCCH3), 25.5 (CH2CH2CvCH),
23.5 (CH3). (S)-18: αD −80.6 (CHCl3, c = 0.5); −106.4 (95%
EtOH, c = 4). (R)-18: αD +93 (CHCl3, c = 0.5); +105.5 (95% EtOH,
c = 4). M.p. 82–92 °C. LRMS (EI+) m/z 140.06 (100%, M+),
136.06 (15), 125.05 (40), 122.06 (100), 95.87 (100), 94.06 (100),
93.07 (80), 79.04 (100), 77.03 (100), 68.06 (90), 67.04 (100) Data
are in agreement with previous work.15,16
(R)- and (S)-4-Methoxybenzyl [(4-methylcyclohex-3-en-1-yl)
methyl]-carbamate (19)
To a solution of 18 (1.3 g, 9.3 mmol) in anhydrous toluene
(20 mL) at 0 °C, diphenylphosphoryl azide (2.2 mL,
10.2 mmol) and Et3N (3.9 mL, 27.8 mmol) were added. The
resulting mixture was left stirring for 3 h at 100 °C before
4-methoxybenzyl alcohol (1.27 mL, 10.2 mmol) was added,
and the reaction was left to stir for 16 h at 100 °C. The reaction
was then allowed to cool to room temperature and the solution
was concentrated under reduced pressure. The residue was the
purified by flash chromatography on silica gel (EtOAc : n-
hexane 1 : 9) to yield 19 as a yellow crystalline solid (1.28 g,
80%). δH (300 MHz, CDCl3) δ 7.23 (2 H, dt, J = 2.9 and 5.3 CH
ArCH), 6.81 (2 H, dt, J = 2.9 and 5.3, ArCH), 5.21 (1 H, br,
HCvC), 4.95 (2 H, s, –OCH2Ph), 4.67–460 (1 H, m, CHN), 3.74
(3 H, s, –OCH3), 2.29–2.20 (2 H, m, CH2–CH2CHN), 1.93 (2 H,
m, CH2–CH2CHN), 2.01–1.86 (2 H, m, CH–CH2CHN), 1.55
(3 H, s, CH3CvCH). δC (75 MHz, CDCl3) δ 159.5 (vCO–CH3),
155.8 (NHCvO), 134.1 (CvCCH3), 130.0 (CvC aromatic),
128.7 (CCH2O), 118.3 (CvCCH3), 113.9 (CvC aromatic), 66.3
(CCH2O), 62.8 (CHN), 55.3 (OCH3), 31.9 (CH2CHN), 28.4
(CH2CvC), 28.0 (CH2CvC), 23.4 (vCCH3). νmax (thin film,
cm−1) 3300 (N–H stretch), 2900–2700 (C–H stretch), 1650
(CvO ester stretch), 1250 (C–N stretch), 830 (aromatic CH
bending); (S)-19: αD −9.3, (c = 0.6, CHCl3) (R)-19: αD +12 (c =
0.6, CHCl3) m.p. 69–71 °C LRMS (EI
+) m/z: 275.15 (100% M+),
276.15 (20), 259.12 (18), 258.12 (60), 231.12 (25), 228.1128(12),
214.16 (100). HRMS (EI+) 275.1522; C16H21NO3 requires
275.1521.
(R)- & (S)-N-Methyl-1-(4-methylcyclohex-3-en-1-yl)methanamine
(20)
To a stirred solution of carbamate 19 (100 mg, 0.4 mmol) in
anhydrous diethyl ether (7 mL) at 0 °C, was added LiAlH4
(50 mg, 1.28 mmol). The mixture was then heated to reflux for
5 h. The reaction was cooled to 0 °C before it was quenched by
the addition of water (6 mL) and an excess of 15% NaOH solu-
tion (6 mL). The resulting mixture was left to stir at 0 °C for
Paper Organic & Biomolecular Chemistry
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1 h and the precipitate was removed by filtration through
a Celite pad. The organic phase was extracted with water
(2 × 10 mL) and the pooled organic layers were then washed
with 10% HCl (2 × 10 mL) and the organic fraction was dis-
carded. The combined aqueous layers were adjusted to pH 12
by dropwise addition of 10% NaOH (15 mL). The product was
extracted with diethyl ether (4 × 15 mL), then dried over anhy-
drous MgSO4, and filtered. The product was then concentrated
carefully under reduced pressure to give 20 as a volatile color-
less oil (20 mg, 40%). δH (300 MHz, CDCl3) 5.24 (1 H, m br,
CHvC), 2.55 (1 H, dt, J = 16.6 and 8.0, CHNH2), 2.37 (3 H, s,
HNCH3), 2.25–2.10 (1 H, m, NH), 1.99–1.87 (2 H, m,
CH2CHvC), 1.87–1.66 (2 H, m, CH2CH2CvCH), 1.61 (1 H,
broad m, CH2CH2CvCH), 1.60 (3 H, s, H2CvCCH3), 1.45–1.26
(1 H, m, CH2CH2CvCH). δC (75 MHz, CDCl3) 134.0
(CvCCH3), 119.1 (CvCCH3), 54.8 (CHNH), 32.7 (CH2CHNH),
32.1 (CvCHCH2CH), 29.7 (CH3N), 29.0 (CH2Cv), 23.4
(CH3Cv) (S)-20: αD −79 (c 1.00, CHCl3) (R)-20: αD +84 (c 1.00,
CHCl3) Data in agreement with previous work.
14a
(R)- and (S)-N,4-Dimethyl-N-(4-methylcyclohex-3-en-1-yl)pent-3-
enamide (21)
To a stirred solution of 20 (172 mg, 1.5 mmol) and DIPEA
(775 mg, 6.0 mmol) in anhydrous DMF (6 mL), HBTU (1.15 g,
3.0 mmol) was added and the resulting mixture was stirred at
room temperature for 20 min before 20 (358 mg, 1.5 mmol)
was added. The reaction was then stirred for 24 h at room
temperature. The mixture was concentrated under reduced
pressure and the residue was dissolved in diethyl ether
(20 mL). The solution was washed with water (2 × 25 mL),
10% NaHCO3 (2 × 25 mL), 10% HCl (2 × 10 mL), and brine
(25 mL) before it was dried over anhydrous MgSO4 and con-
centrated under reduced pressure. The residue was purified
by flash chromatography on silica gel (EtOAc : hexane 4 : 6)
yielding 21 as a colorless oil (166 mg, 50%). δH (400 MHz,
CDCl3) 5.24 (2 H, dd, J = 14.6 and 8.0, NCHCH2CHv and
vCHCH2CvO), 4.70–4.54 (0.5 H, m, CHN), 3.75 (0.5 H, dd,
J = 12.6 and 9.7, CHN), 3.01 (2 H, dd, J = 12.6, 6.8 Hz,
CH2CvO), 2.75 (1.5 H, s, CH3N), 2.72 (1.5 H, s, CH3N),
2.20–1.86 (5 H, m, CH2CH2CHCH2), 1.71–1.88 (1 H, m,
CH2CH2CHCH2), 1.75 (s, 3 H, CNCH2vCHCH3), 1.68 (3 H, s,
vCCH3), 1.66 (3 H, s, vCCH3). (S)-21: αD −9.5, (CHCl3, c =
0.9) (R)-21: αD +10, (CHCl3, c = 0.9) HRMS (EI
+) 221.1779;
C14H23NO requires 221.1780. Data are in agreement with pre-
vious work.14a
(R)- and (S)-N,4-Dimethyl-N-(4-methylpent-3-en-3-yl)cyclohex-3-
en-1 ammonium chloride (11)
To a stirred solution of 21 (41 mg, 0.19 mmol) in anhydrous
diethyl ether at 0 °C, was added LiAlH4 (33 mg, 0.87 mmol).
The mixture was heated to reflux for 6 h then allowed to cool
to room temperature and stirred for a further 12 h. The reac-
tion was quenched by the addition of water (6 mL) and 15%
NaOH (6 mL) at 0 °C and stirred for 1 h at 0 °C. The white pre-
cipitate was removed by filtration on Celite and the filtrate was
extracted with diethyl ether (2 × 25 mL). The combined
organic layers were dried over anhydrous Na2SO4, concentrated
under reduced pressure, and the residue was purified by flash
chromatography on silica (Et2O :MeOH 1 : 9) to yield the
amine as a yellow oil (32 mg, 65% yield). δH (300 MHz, CDCl3)
5.27 (1 H, d, J = 2.4, H3CCvCH), 5.03 (1H, t, J = 5.6,
(CH3)2CvCH), 2.64–2.44 (1 H, m, CHN), 2.38 (2 H, ddd, J = 7.6,
5.8 and 2.6, CH2N), 2.23 (3 H, s, CH3N), 2.08 (2 H, dd, J = 15.5
and 7.2, CH2CH2N), 2.04–1.85 (4 H, m, CH2CH2CHN),
1.85–1.67 (2 H, m, CvCHCH2CHN), 1.62 (3 H, s, CH3CvCH),
1.55 and 1.57 (2 × 3 H, 2 × s, (CH3)2CvCH). δC (75 MHz,
CDCl3) δ 133.9 (HCvCCH3), 132.6 (CHvCCH3), 122.1
(CHvCCH3), 120.0 (NCH2CH2CHvCCH3), 58.9 (CHN), 53.5
(CH2N), 37.9 (CH2CH2CHN), 30.8 (vCHCH2N), 27.2
(CH2CCH3), 26.5 (CH3N), 25.7(CH2CH2N), 25.6 (CH3CCH3),
23.2 (CH3CCH3), 17.8 (CH3Cv). HRMS (EI
+) 207.1990;
C14H25N requires 207.1987. (S)-11: αD −61 (CHCl3, c = 1) (R)-11
αD +63 (CHCl3, c = 1). Data are in agreement with previous
work.14a The amine was then dissolved in Et2O (1 mL) and HCl
(1 M in anhydrous Et2O) was added slowly. A light yellow pre-
cipitate was formed. The ether was concentrated under
reduced pressure and the salt stored in 1.2 mL of deionised
water. δH (300 MHz, MeOD) 5.38 (1 H, br, H3CCvCH), 5.14
(1 H, t, J = 5.0, (CH3)2CvCH), 3.58–3.42 (1 H, m, CHN), 3.32
(1 H, dd, J = 4.9, 1.6, CHHCH2N), 3.25–2.97 (1 H, m,
CHHCH2N), 2.85 (3 H, s, CH3N), 2.59–2.39 (2 H, m,
CH2CH2CHN), 2.39–2.26 (2 H, m, CH2CH2CHN), 2.26–2.05
(2 H, m, CvCHCH2CH2N), 1.84 (2 H, dd, J = 12.2, 10.4 Hz,
CH3CvCHCH2), 1.76 (3 H, s, CH3CvCH), 1.72 (6 H, 2 × s,
(CH3)2CvCH). δC (75 MHz, MeOD) δ 136.1 (HCvCCH3), 134.3
(CHvC(CH3)2) 117.6 (CHvCCH3) 116.5 (NCH2CH2
CHvCCH3), 61.8, 61.5 (CHN), 53.0, 52.5 (CH2N), 35.9, 35.2
(CH3N) 29.1, 29.0 (CH2CH2CHN), 25.7 (vCHCH2N), 24.5
(CH2CCH3), 24.2, 24.0 (NCH2CH2), 23.25, 22.64 (CH3Cv),
21.64 (CH3CCH3), 16.65 (CH3CCH3). νmax (neat, cm
−1) 2972
(broad, N–H stretch), 1379 (C–N stretch), 1161, 1051 and 1022
(C–N stretch), 950, 879, 815; HRMS (APCI+) 208.2057, C14H26N
requires 208.2065; m.p. 131–133 °C, (S)-11 αD −62.2 (MeOH,
c = 0.09), (R)-11 αD +57.1 (MeOH, c = 0.09). Data are in agree-
ment with previous work.14a
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